--- title: "Zepbound prior authorization denied: what to do next | Peptyn" description: "The real deadlines for appealing a GLP-1 prior authorization denial, which denials qualify for independent external review, and what paperwork to keep." canonical: "https://peptyn.orlyn.ai/articles/prior-authorization-denied-glp1" last-updated: "2026-08-16" --- # Zepbound prior authorization was denied. Here is what you can actually do. *The real deadlines for appealing a GLP-1 prior authorization denial, which denials qualify for independent external review, and what paperwork to keep.* Educational · Not medical advice · 18+ A prior authorization denial is not the end of the process. It is the start of one, and that process has legal deadlines attached to it in both directions: deadlines the plan has to meet, and deadlines you have to meet. Published 15 August 2026 · 9 min read · 8 sources Most people miss the second kind, because the denial letter is written to be skimmed and put down. This article covers what the appeal routes actually are, the real numbers on the clock, which denials can be escalated past the insurance company entirely, and what paperwork is worth keeping. It does not cover what to take or how much. Nothing here is medical advice, and coverage rules are decided by your plan and your prescriber, not by an article. ## You have two appeals, not three There is a common belief that appeals run in three escalating levels inside the insurance company. That is not how the federal framework is structured. HealthCare.gov describes two routes: 1. **Internal appeal.** You ask the insurance company to conduct a full and fair review of its own decision. 2. **External review.** You take the decision to an independent third party. As HealthCare.gov puts it, external review "means that the insurance company no longer gets the final say over whether to pay a claim."[1] Some employer plans do layer a second internal review before you reach external review, so read your own denial notice for the sequence your plan uses. But the escalation that matters, the one that removes the decision from the company that made it, is external review.[1][3] Whether it is available to you at all depends on what kind of plan you have, which is the next section. ## First, work out which rulebook you are under Every number in this article comes from one framework: the federal rules for non-grandfathered private health coverage, meaning individual market plans and most employer plans. If that is what you have, the deadlines below are yours. If it is not, they are not, and the gaps are wide enough to miss a deadline over. **Medicare Part D.** If the medication is billed through a Part D drug plan, you do not have 180 days. You have 60. The regulation is explicit that "a request for a redetermination must be filed within 60 calendar days after receipt of the written coverage determination notice."[7] The same section presumes that receipt happened "5 calendar days after the date of the written coverage determination," unless there is evidence to the contrary, so the clock is shorter than it looks.[7] A plan sponsor may extend the filing window if you show good cause, but that is something you have to ask for, not something you have.[7] **Grandfathered plans.** External review is not universal either. The rule that creates it opens by carving older plans out: "The provisions of this section generally do not apply to coverage offered by health insurance issuers and group health plans that are grandfathered health plans."[8] The exception written into that same paragraph covers out-of-network emergency services, nonemergency services performed by nonparticipating providers at participating facilities, and air ambulance services, none of which is the situation when a GLP-1 prescription is denied for coverage reasons.[8] Your plan documents say whether your plan is grandfathered, and the denial notice should tell you what review rights come with it. **Everything else.** Medicare Advantage, Medicaid, the VA and TRICARE each run their own appeals process on their own clock. This article does not cover them, and reading the numbers below as if they applied is the exact mistake this section exists to prevent. ## The deadlines, with the real numbers These are the federal standards described by HealthCare.gov for the plan types named above. Your plan documents and your denial notice govern your specific case, and self-funded employer plans can run on different internal timelines, so check the notice. **Before the denial: how fast the plan must answer.** For a prior authorization, meaning a treatment you have not received yet, the insurer must notify you in writing and explain why within 15 days. For services already received it is 30 days, and for urgent care cases it is 72 hours.[2] **Your deadline to file the internal appeal: 180 days.** You must file within 180 days, six months, of receiving notice that the claim was denied.[2] This is the number most often gotten wrong, usually in the alarming direction. If you were told you had 30 days, check the notice. **The plan's deadline to finish the internal appeal.** Thirty days if the appeal is for a service you have not received yet, which is the prior authorization case. Sixty days if the service was already received. At the end, the insurer must give you a written decision, and if it is still a denial, that final determination has to tell you how to request an external review.[2] **If it is urgent.** You can file an expedited appeal if the standard timeline would seriously jeopardize your life or your ability to regain maximum function, and you may file the internal appeal and the external review request at the same time rather than waiting. A decision on an expedited appeal must come as quickly as your condition requires and within 4 business days of the request. It can be delivered verbally, followed by written notice within 48 hours.[2] **Your deadline to request external review: 4 months.** You must file a written request within 4 months after the date you receive the final determination.[3] As of 15 August 2026 there is a live exception to that on the same page: "You may be eligible for an extension until October 2, 2026 to request an external review" if your original deadline fell between 1 July 2026 and 3 August 2026 and your plan uses the HHS-administered Federal External Review Process, which HealthCare.gov says may affect you in Alabama, Florida, Georgia, Texas, Wisconsin, a US territory other than Puerto Rico, or on a state or local government plan in any state.[3] That notice is dated and will come down, so read the page rather than this sentence, and ask your plan whether it uses that process. **The external reviewer's deadline.** Standard external reviews are decided no later than 45 days after the request is received. Expedited external reviews are decided no later than 72 hours.[3] **The part that gives external review its teeth.** The reviewer either upholds the insurer's decision or decides in your favor, and your insurer is required by law to accept that decision.[3] ## Not every denial can go to external review This is the detail worth knowing before you spend weeks on paperwork, and it is where GLP-1 denials split into two very different situations. External review covers denials that involve medical judgment, denials that call a treatment experimental or investigational, and cancellation of coverage on the grounds that you gave false or incomplete information when you applied.[3] HealthCare.gov separately lists the reasons a plan might issue a denial in the first place, and they include both "the requested service or treatment is 'not medically necessary'" and "the benefit isn't offered under your health plan."[2] Those two are not the same fight. A "not medically necessary" denial is a medical judgment call. That is squarely the kind of decision an independent reviewer exists to look at. "The benefit isn't offered under your health plan" is a plan design question, not a medical judgment. If your employer's plan simply excludes weight management drugs as a category, an appeal is arguing against the contract rather than against a clinical decision, and external review is not built for that. It is worth identifying which of the two you received before deciding how much effort to put where. Your plan documents, or a call to the appeals number on the notice, will tell you which exclusion is being applied. ## Why the indication on the prescription matters so much Coverage is decided against a specific approved use, and the GLP-1 and GIP class does not have one single approved use. This is why two people on chemically related medications can get opposite coverage answers. The FDA label for Zepbound (tirzepatide) lists it as indicated in combination with a reduced-calorie diet and increased physical activity, for adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition, and separately for moderate to severe obstructive sleep apnea in adults with obesity.[4] Two things in that sentence tend to show up verbatim in plan criteria: the comorbid condition requirement for the overweight population, and diet and physical activity as part of the indication itself. Documentation gaps on either point are ordinary reasons a request comes back for more information. Semaglutide injection is a useful contrast. MedlinePlus lists it as used to control blood sugar in certain patients with type 2 diabetes, to reduce the risk of heart attack, stroke or death in defined populations, to reduce the risk of worsening kidney disease in certain adults with type 2 diabetes and kidney disease, to assist with weight loss in certain people who are obese or overweight and have weight-related medical problems, and to treat noncirrhotic MASH in people with liver disease.[5] Those are different indications, carried by different brand products, and plans frequently cover them under different rules. None of this tells you what should be prescribed for you. That is your prescriber's call. It explains why "which documented indication is this request being made under" is a reasonable question to ask the prescribing office when a request comes back denied. ## What a letter of medical necessity is A letter of medical necessity is a letter from your prescriber to the insurance company making the clinical case for coverage. It is not a prescription. It is an explanation, and it is a routine part of the appeals process rather than an unusual favor to ask for. It generally addresses your identifying and insurance information, the medication prescribed, the diagnosed condition it is being prescribed for, why it is appropriate for your specific situation rather than in general, what has been tried before and why that was inadequate, and the prescriber's signature and credentials. The letter does not need to promise an outcome. It needs to address the plan's own stated criteria, which is why getting the specific denial reason in writing comes first. ## Paperwork worth keeping HealthCare.gov's guidance on internal appeals includes a list of what to hold onto, and it is more specific than most people expect. Keep the Explanation of Benefits forms or letters showing what was denied, a copy of the internal appeal request you sent, any additional information you sent in, a copy of any form you signed to let someone else appeal on your behalf, and notes and dates from phone calls with the insurer or your doctor, including the day, time, name and title of the person you spoke to. Keep your originals and send copies.[2] Two practical notes from the same sources. You may appoint a representative, such as your doctor, to file an external review for you.[3] And your prescriber's office is often the most experienced party in the room here: healthinsurance.org notes that a plan may deny a request initially and approve it after receiving additional information, and that a doctor's office is likely well versed in responding to prior authorization denials.[6] If cost is a worry: under the HHS-administered federal external review process there is no charge, and where an insurer uses a contracted independent review organization or a state process, the charge cannot exceed $25.[3] ## Where a log actually fits Peptyn keeps a dated record of what you logged and when: doses and injection sites on a history calendar, weight on a separate progress screen. That is the honest description of what it is for. It does not compute doses and it does not decide anything clinically. It will hand you the record as a file. Settings has a CSV export that writes out every dose, every mix, and every weight entry you have logged, one row each, with the date, compound, protocol, the amount you entered, the site, the vial figures you entered, and the weight with its unit. It is a plain spreadsheet file, so it opens in anything and it is yours to attach, print, or forward. What that gives you is the ability to answer date questions without reconstructing them from memory. When did this start. Has it been taken on schedule. What changed and when. Those are the questions a prescriber's office asks while assembling a clinical narrative, and reading them off a log is faster and more accurate than guessing at them nine months later. To be explicit, because this is the sort of claim that gets overstated: keeping a log does not improve your odds of approval, and nothing here suggests it does. Coverage decisions rest on the plan's criteria and your prescriber's clinical documentation. A log is a memory aid for you and a source of dates for the person writing that documentation. That is the whole of the claim. ## The one thing to do today Find the denial notice and read it for three things: the specific reason given, the appeal deadline it states, and the phone number for the appeals department. If the reason is vague, call and ask for the specific criterion that was not met, in writing. You cannot answer a denial you have not been told the grounds for, and the deadline is running from the date on that notice. ## References 1. HealthCare.gov, "How to appeal an insurance company decision," 2. HealthCare.gov, "Internal appeals," 3. HealthCare.gov, "External Review," 4. DailyMed, "ZEPBOUND (tirzepatide) injection, solution," 5. MedlinePlus, "Semaglutide Injection," 6. HealthInsurance.org, "Prior authorization," 7. 42 CFR 423.582, "Request for a standard redetermination" (Medicare Part D). U.S. Government Publishing Office, CFR annual edition revised as of 1 October 2025. 8. 45 CFR 147.136(a)(1)(ii), "Internal claims and appeals and external review processes," application to grandfathered health plans. U.S. Government Publishing Office, CFR annual edition revised as of 1 October 2025. ## Keep reading - [What to bring to a GLP-1 follow-up](https://peptyn.orlyn.ai/articles/glp1-follow-up-visit-packet) How to turn your own records into a one-page packet, and which questions are worth a prescriber's time. - [The glossary that will not do your math](https://peptyn.orlyn.ai/articles/peptide-glossary) Plain definitions from lyophilized to 503A, with sources. It defines every term and stops where the arithmetic starts. - [Compounded GLP-1s: the 2026 timeline](https://peptyn.orlyn.ai/articles/compounded-glp1-2026-regulatory-changes) Every date traced to an FDA or Federal Register document, and why your own log is what carries across a formulation change. This article is educational. It does not recommend doses, schedules, or products, and it is not medical advice. Every factual claim above is linked to its source. Questions about your own protocol belong with the prescriber who wrote it. --- Source: